Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets slip into the red
Fri, 1 Feb 01:30 pm

Indian stock markets, lost the initial gains and fell below the dotted line during the post noon trading session. Majority of the sectoral indices are trading in the negative territory with realty, banking and IT stocks being the biggest losers.

BSE-Sensex is down by 78 points and NSE-Nifty is trading down by 25 points. While the BSE Mid Cap is trading up by 0.03%, BSE Small Cap index is trading up by 0.03%. The rupee is trading at 53.29 to the US dollar.

Most of the pharma stocks are trading in the green with Lupin Ltd and Aurobindo Pharma being among the top gainers. Sun Pharma has announced that its shareholders have given the green signal to spin off its domestic formulations operations into a new entity called Sun Pharma Laboratories Ltd. The new entity will be a wholly owned subsidiary of Sun Pharmaceuticals Industries Ltd (SPIL). Reportedly, both the domestic and international segments of the company are growing well. And Sun Pharma's rationale for spinning off the domestic segment is that it will help the company maintain its growth momentum. Further, it will also help it focus on each of the operations individually. The assets of the domestic formulations business will be transferred to the transferee company. The stock is trading up by 0.5%.

Telecom stocks are trading mixed with AGC Networks and Tata Teleservices being the biggest gainers and Bharti Airtel and ITI leading among the losers. Bharti Airtel has declared its financial results for the quarter ended December 2012. The company recorded a 9.4% YoY increase in sales during the quarter. The growth was brought about by the increase in revenues from all of its segments. However, its operating margins contracted by 170 basis points (1.7%) to 30.5% on account of higher network operating expenses. At the net level, the company's earnings dipped by 72% YoY largely due to increase in the interest expense, by around 69%. Even the tax outgo rose by 19% as a result of higher tax incidence, reducing net profits for the quarter. The stock is trading down by 0.8%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets slip into the red". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.